The Integrated BioBank of Luxembourg (IBBL) has become the first biobank in the world to be accredited for next-generation 16S rRNA gene sequencing.
The IBBL has been recognised for its next-generation microbial sequencing method that takes forward research into the human microbiome.
In this particular case, the next-generation 16S rRNA gene sequencing consists of identifying not only one single bacteria but the whole set of bacteria within a given sample of any kind. Scientists have therefore a reliable full-length insight at their disposal, which enables them to progress with their research.
Marc Vandelaer, the CEO of IBBL, commented that: “IBBL makes history in the biobanking world. The accreditation for the next-generation 16S rRNA gene sequencing assures confidence that IBBL successfully fulfils its mission as a biobank. Above all, we are proud to contribute to a promising research area in which Luxembourg is very active”.
Moreover, IBBL has announced that registration for its 2017 biospecimen proficiency testing programme will open in the second quarter of the year.
